Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term

Impact of primary medical or surgical therapy on prolactinoma patients’ BMI and metabolic profile over the long-term

Objectives: High prolactin levels have been associated with weight gain and impaired metabolic profiles. While treatment with dopamine agonists (DAs) has been shown to improve these parameters, there is a lack of surgical series on its comparative effect in prolactinoma patients. Methods: In this re...

Full description

Bibliographic Details
Main Authors: Lukas Andereggen, Janine Frey, Robert H. Andres, Markus M. Luedi, Jan Gralla, Gerrit A. Schubert, Jürgen Beck, Luigi Mariani, Emanuel Christ
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:Journal of Clinical & Translational Endocrinology
Subjects:
BMI
Dopamine agonist
Metabolic profile
Prolactinoma
Surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623721000107

Internet

http://www.sciencedirect.com/science/article/pii/S2214623721000107

Similar Items